4/2
Penn in the News
A round-up of Penn mentions in local, national, and international media.
Filter Stories
Penn In the News
Scholars at risk in their own countries find a new home at Penn
Penn Global’s Scholars-at-Risk program is featured. Global’s Ezekiel J. Emanuel and Scott Moore, Penn Carey Law’s Eric Feldman, and Wharton’s Jesús Fernández-Villaverde, along with former and current scholars Angel Alvarado, Pavel Golubev, and Jawad Moradi are interviewed.
Penn In the News
Sugar-coated gold nanoparticles could replace some antibiotics
According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.
Penn In the News
A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.
Penn In the News
Alzheimer’s may be caused by a build-up of fat in brain cells
A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.
Penn In the News
Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors
A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.
Penn In the News
Social factors may ‘disproportionately’ affect transplant process
A 2023 study led by researchers at Penn found that 44% of patients evaluated for liver transplants were not placed on organ wait lists, with nearly 17% rejected because of psychosocial or financial reasons. Marina Serper and Tamara Cozzi of Penn Medicine discuss the evaluation process for transplants.
Penn In the News
ALS drug fails large clinical trial and may be withdrawn from market
Holly Fernandez Lynch of the Perelman School of Medicine says that the lack of good treatment options for ALS has led to an insatiable desire to develop something that is going to modify the course of this disease.
Penn In the News
Best CPAP alternatives
Richard Schwab of the Perelman School of Medicine says that obstructive sleep apnea causes breathing to pause during sleep when something like the tongue or relaxed throat muscles blocks the airway.
Penn In the News
This day of silence brings a fresh start for Bali’s new year
Mathias Basner of the Perelman School of Medicine says that human bodies interpret noise as a stressor, which can initiate increased levels of stress hormones like cortisol and adrenaline in the blood.
Penn In the News
Apparently healthy, but diagnosed with Alzheimer’s?
Jason Karlawish of the Perelman School of Medicine says that amyloid is a risk factor for Alzheimer’s in the same way that smoking is a risk factor for cancer.